← Back to Clinical Trials
Recruiting NCT06682520

NCT06682520 Evaluation of a Health System Integrated Model for Postpartum Education and Support in Rural Populations

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06682520
Status Recruiting
Phase —
Sponsor Wake Forest University Health Sciences
Condition Health Care Utilization
Study Type INTERVENTIONAL
Enrollment 1,300 participants
Start Date 2024-12-04
Primary Completion 2027-10

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Postpartum NEST-Rural Program (Hospital based service model)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,300 participants in total. It began in 2024-12-04 with a primary completion date of 2027-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study was designed to evaluate the implementation of the Nurse Education and Support Team (NEST) Program for postpartum women who reside in 5 rural counties in North Carolina. Overarching Hypothesis: Mothers and infants residing in rural communities, randomized to the NEST-Rural care model over the 3-year course of the project will: 1. Receive more coordinated care for addressing social, mental and physical health needs. 2. Experience fewer postpartum hospital readmissions and decreased utilization of emergency departments (ED) for healthcare. 3. Experience higher adherence to American College of Obstetricians and Gynecologists (ACOG) and American Academy of Pediatrics (AAP) guidelines for preventive care, including recently updated ongoing postpartum care, serial well-child visits and vaccinations compared to those assigned to usual care. This group will be compared to those assigned to usual care,

Eligibility Criteria

Inclusion Criteria: 1. Women that deliver an infant(s) at The Birth Center at Atrium Health Wake Forest Baptist and currently reside in Davidson, Davie, Stokes, Wilkes or Yadkin County in North Carolina 2. Women that delivered an infant(s) at home, were transported to Atrium Health Wake Forest Baptist and received postpartum care at The Birth Center and currently reside in Davidson, Davie, Stokes, Wilkes or Yadkin County in North Carolina 3. Ages 18 years or older Exclusion Criteria: 1. Women that delivered an infant(s) and did not receive postpartum care at The Birth Center at Atrium Health Wake Forest Baptist. 2. Women that currently reside outside of Davidson, Davie, Stokes, Wilkes or Yadkin County in North Carolina 3. Under 18 years of age

Contact & Investigator

Central Contact

Elizabeth T. Jensen, MPH PhD

✉ elizabeth.jensen@wfusm.edu

📞 336-713-3132

Principal Investigator

Elizabeth T. Jensen, MPH PhD

PRINCIPAL INVESTIGATOR

Wake Forest University Health Sciences

Frequently Asked Questions

Who can join the NCT06682520 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Health Care Utilization. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06682520 currently recruiting?

Yes, NCT06682520 is actively recruiting participants. Contact the research team at elizabeth.jensen@wfusm.edu for enrollment information.

Where is the NCT06682520 trial being conducted?

This trial is being conducted at Winston-Salem, United States.

Who is sponsoring the NCT06682520 clinical trial?

NCT06682520 is sponsored by Wake Forest University Health Sciences. The principal investigator is Elizabeth T. Jensen, MPH PhD at Wake Forest University Health Sciences. The trial plans to enroll 1,300 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology